Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  1996

• Venue

  NeuroReport

• Publication date

  1996-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00001756-199612200-00006PMID 9051746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TrkA activation is sufficient to rescue axotomized cholinergic neurons.

  1996cited by this paper
• Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody

  1996cited by this paper
• Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins

  1995cited by this paper
• Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits

  1995cited by this paper
• Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis

  1995cited by this paper
• Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis

  1995cited by this paper
• Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats.

  1994cited by this paper
• The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.

  1994cited by this paper
• Nerve growth factor‐like immunoreactive profiles in the primate basal forebrain and hippocampal formation

  1994cited by this paper
• Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells.

  1994cited by this paper
• Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease

  1993cited by this paper
• The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons.

  1992cited by this paper
• Nerve growth factor mediates signal transduction through trk homodimer receptors.

  1992cited by this paper
• Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

  1991cited by this paper
• Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family.

  1990cited by this paper
• Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain.

  1989cited by this paper
• Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases.

  1989cited by this paper
• NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease.

  1989cited by this paper
• Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

  1987cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

  1983cited by this paper

• The cholinotrophic system in Down syndrome.

  2025cites this paper
• Age-induced nitrative stress decreases retrograde transport of proNGF via TrkA and increases proNGF retrograde transport and neurodegeneration via p75NTR

  2023cites this paper
• Long‐term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis

  2022cites this paper
• Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease

  2022cites this paper
• Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease

  2021cites this paper
• Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy

  2021cites this paper
• TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon γ-secretase inhibition

  2021cites this paper
• Effects of Reactive Oxygen and Nitrogen Species on TrkA Expression and Signalling: Implications for proNGF in Aging and Alzheimer’s Disease

  2021cites this paper
• Chronic traumatic encephalopathy and the nucleus basalis of Meynert.

  2021cites this paper
• The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain

  2021cites this paper
• Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer’s Disease

  2020cites this paper
• Pro ling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer’s Disease

  2020cites this paper
• ProNGF and Neurodegeneration in Alzheimer’s Disease

  2019cites this paper
• Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin

  2018cites this paper
• Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons.

  2018cites this paper
• A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.

  2017cites this paper
• Cholinergic degeneration in early stages of Alzheimer’s disease: Loss of cholinergic phenotype or loss of cells?

  2017cites this paper
• Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

  2017cites this paper
• Regulatory role of NGFs in neurocognitive functions

  2017cites this paper
• Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease

  2016cites this paper
• Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

  2016cites this paper
• Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy

  2016cites this paper
• Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.

  2015cites this paper
• Estradiol modulation of neurotrophin receptor expression in female mouse basal forebrain cholinergic neurons in vivo.

  2015cites this paper
• The expression of the TrkA and TrkB high-affinity neurotrophin receptors in the rat hippocampus after intracerebroventricular administration of Aβ(25–35)

  2015cites this paper
• Development of subnanomolar radiofluorinated (2-pyrrolidin-1-yl)imidazo[1,2-b]pyridazine pan-Trk inhibitors as candidate PET imaging probes

  2015cites this paper
• The triple power of D³: protein intrinsic disorder in degenerative diseases.

  2014cites this paper
• Molecular and morphological analyses of basal forebrain cholinergic neurons in mouse models of aging and Alzheimer's disease

  2013influential citation
• The effects of anticholinesterases and β-amyloid pathology on neurotrophin signaling in the mouse brain

  2013cites this paper
• A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer’s mouse model

  2013cites this paper
• Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases

  2012cites this paper
• Ectopic expression of TrKA in the adult rat basal ganglia induces both nerve growth factor‐dependent and ‐independent neuronal responses

  2012cites this paper
• The Relationship between Choline Acetyltransferase and Nitric Oxide Synthase Isoform Expression in Alzheimer's Disease

  2012cites this paper
• The history of the cholinergic hypothesis.

  2011cites this paper
• Endogenous Aβ causes cell death via early tau hyperphosphorylation.

  2011cites this paper
• Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease

  2010cites this paper
• Intrinsic disorder in proteins associated with neurodegenerative diseases.

  2009cites this paper
• Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease

  2008cites this paper
• Analysis of alteration of p75NTR processing and signalling by PS2 mutation and gamma-secretase inhibition.

  2007cites this paper
• On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease

  2006cites this paper
• Nerve Growth Factor, Neural Stem Cells and Alzheimer’s Disease

  2006cites this paper
• Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease

  2006cites this paper
• Increased Metabolic Activity in Nucleus Basalis of Meynert Neurons in Elderly Individuals With Mild Cognitive Impairment as Indicated by the Size of the Golgi Apparatus

  2006cites this paper
• P75 neurotrophin receptor regulates expression of neural cell adhesion molecule 1.

  2005cites this paper
• Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease

  2004cites this paper
• Neuroplasticity in the human hypothalamus during aging

  2004cites this paper
• Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease

  2004cites this paper
• Alzheimer’s disease and NGF signaling

  2004cites this paper
• Age-related sex differences in spatial learning and basal forebrain cholinergic neurons in F344 rats.

  2003cites this paper
• Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.

  2003cites this paper
• Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection.

  2003cites this paper
• Traffic at the intersection of neurotrophic factor signaling and neurodegeneration.

  2003cites this paper
• Reactivation of atrophic neurons in Alzheimer's disease

  2003cites this paper
• Role of the medial septum diagonal band of Broca cholinergic neurons in oestrogen‐induced spine synapse formation on hippocampal CA1 pyramidal cells of female rats

  2003cites this paper
• Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

  2002cites this paper
• Early Events of Alzheimer-Like Neurodegeneration in Anti-Nerve Growth Factor Transgenic Mice

  2002cites this paper
• Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

  2002cites this paper
• The cholinergic pathology in Alzheimer's disease – discrepancies between clinical experience and pathophysiological findings

  2002cites this paper
• The effects of chronic ethanol consumption on neurotrophins and their receptors in the rat hippocampus and basal forebrain.

  2002cites this paper
• Brain aging and Alzheimer's disease; use it or lose it.

  2002cites this paper
• Gene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease

  2002cites this paper
• Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer’s disease

  2001cites this paper
• Infusion of nerve growth factor (NGF) into kitten visual cortex increases immunoreactivity for NGF, NGF receptors, and choline acetyltransferase in basal forebrain without affecting ocular dominance plasticity or column development.

  2001cites this paper
• Hippocampal tyrosine kinase A receptors are restricted primarily to presynaptic vesicle clusters

  2001cites this paper
• Difference in toxicity of β-amyloid peptide with aging in relation to nerve growth factor content in rat brain

  2001cites this paper
• The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.

  2001cites this paper
• Molecular and cellular mediators of Alzheimer's disease inflammation

  2001cites this paper
• The common neurotrophin receptor p75NTR enhances the ability of PC12 cells to resist oxidative stress by a trkA-dependent mechanism

  2001cites this paper
• Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation.

  2001cites this paper
• Down‐regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease

  2001cites this paper
• Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.

  2001cites this paper
• Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease.

  2001cites this paper
• Cholinergic Basal Forebrain Systems in the Primate Central Nervous System: Anatomy, Connectivity, Neurochemistry, Aging, Dementia, and Experimental Therapeutics

  2001cites this paper
• Cellular and molecular mechanisms of Alzheimer’s disease inflammation

  2001cites this paper
• Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease.

  2000cites this paper
• P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease.

  2000cites this paper
• Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

  2000cites this paper
• Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.

  2000cites this paper
• Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

  2000cites this paper
• Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.

  2000cites this paper
• Reduction in TrkA‐Immunoreactive Neurons Is Not Associated with an Overexpression of Galaninergic Fibers Within the Nucleus Basalis in Down's Syndrome

  2000cites this paper
• Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

  2000cites this paper
• NF-κB Signaling Promotes Both Cell Survival and Neurite Process Formation in Nerve Growth Factor-Stimulated PC12 Cells

  2000cites this paper
• Nerve Growth Factor Treatment in Dementia

  2000cites this paper
• Estrogen and Brain Aging

  1999cites this paper
• Neurotrophic Factors, Gene Therapy, and Alzheimer's Disease

  1999cites this paper
• Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase.

  1999cites this paper
• Nerve Growth Factor Systems in Alzheimer’s Disease

  1999cites this paper
• Molekulare Medizin der Alzheimer-Krankheit

  1999cites this paper
• Age-related changes in rodent cortical acetylcholine and cognition: main effects of age versus age as an intervening variable.

  1998cites this paper
• The time course of nerve growth factor content in different neuropsychiatric diseases – a unifying hypothesis

  1998influential citation
• Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.

  1998cites this paper
• Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging.

  1998cites this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cites this paper
• Nerve Growth Factor and Its Receptors in the Primate Forebrain

  1998cites this paper
• Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.

  1998cites this paper
• Tyrosine kinase A, galanin and nitric oxide synthase within basal forebrain neurons in the rat.

  1998cites this paper
• m2 muscarinic acetylcholine receptor‐immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: Relationship with cholinergic and galaninergic perikarya

  1998cites this paper
• Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease.

  1998cites this paper
• Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement.

  1998cites this paper